Kineta Number of Employees 2014-2024 | KANT
Kineta number of employees from 2014 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
Kineta Annual Employee Count |
2023 |
11 |
2022 |
12 |
2021 |
41 |
2020 |
44 |
2019 |
44 |
2018 |
49 |
2017 |
52 |
2016 |
73 |
2015 |
43 |
2014 |
43 |
2013 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.000B |
$0.005B |
Kineta, Inc. is a clinical-stage biotechnology company. It develops next-generation immunotherapies that address the major challenges with current cancer therapy. The company's lead asset is KVA12123, a novel VISTA blocking immunotherapy. Kineta merged with Yumanity Therapeutics, Inc., and is based in Seattle.
|